CMS Finalizes 2027 Medicare Advantage Payment Increase: Insurers Rally as Funding Surges
In a move that caught the healthcare industry by surprise, the Centers for Medicare & Medicaid Services (CMS) announced on Monday a finalized 2027 Medicare Advantage payment increase that dwarfs its own earlier projections.
The agency estimates that its finalized policies will inject an average increase of 2.48%—amounting to roughly $13 billion—into Medicare Advantage plans for 2027.
This final figure represents a dramatic pivot from the initial January proposal, which suggested a near-flat increase of just 0.09%, or approximately $700 million.
“Medicare Advantage and Part D should work for the people who rely on them,” CMS Administrator Dr. Mehmet Oz stated, emphasizing that these updates are designed to maintain affordability while ensuring patients receive genuine value.
The “Risk Score” Multiplier: A Deeper Look at the Numbers
While the base increase is 2.48%, the actual financial impact is more substantial. When accounting for estimated trends in risk scores—driven by evolving coding practices and population shifts—the average increase effectively jumps to 4.98%.
According to CMS, the finalized 2027 rates integrate several critical variables, including the growth of underlying plan costs and the 2026 Star Ratings, which dictate quality bonus payments.
Chris Klomp, director of Medicare and chief counselor of the U.S. Department of Health and Human Services (HHS), noted that the goal is to move the program toward long-term sustainability.
“The rate announcement improves payment accuracy and strengthens competition based on quality—not on coding practices,” Klomp said.
Wall Street Cheers While Providers Struggle
The financial markets reacted with immediate enthusiasm. Following the announcement, shares of industry giants UnitedHealth (NYSE: UNH), CVS (NYSE: CVS), and Humana surged between 8% and 14% in extended trading, as detailed in a Reuters report.
However, the optimism on Wall Street is not shared equally by those on the front lines of care. Home health providers continue to battle a “perfect storm” of payment cuts and persistently low reimbursement rates.
Susan Ponder-Stansel, CEO of Alivia Care, has previously highlighted the dire nature of these reimbursement struggles.
“Patients are getting the care, which is great, but a lot are not getting the care because the home health companies can’t afford to take them,” Ponder-Stansel warned, adding that smaller agencies are being forced to close their doors.
Will this sudden influx of $13 billion actually trickle down to the providers who deliver care, or will it remain locked in the balance sheets of the major insurers?
Furthermore, as Medicare Advantage penetration increases, does this payment hike solve the sustainability crisis, or is it merely a temporary bandage on a systemic wound?
For those seeking the granular data, the official CMS fact sheet provides a comprehensive breakdown of the finalized 2027 rates.
The Pattern of CMS Reimbursement: Why the Gap Exists
This discrepancy between the “proposed” and “finalized” rates is not a new phenomenon. In a striking parallel, CMS proposed a 2.2% increase for the 2026 reimbursement cycle, only to finalize it at a much higher 5.06% after reviewing the 2026 payment policy updates.
CMS typically attributes these jumps to a “higher effective growth rate” and updated data on the cost of care. For stakeholders, this creates a volatile environment where initial budget projections are often rendered obsolete by the final ruling.
To understand the broader context, it is helpful to visit the official Medicare website to see how these plan changes impact individual beneficiary options.
Frequently Asked Questions
- What is the finalized 2027 Medicare Advantage payment increase?
- The finalized average increase is 2.48%, which translates to approximately $13 billion in additional payments to plans.
- How does the 2027 Medicare Advantage payment increase compare to the proposal?
- It is substantially higher; the initial January proposal estimated an increase of only 0.09% ($700 million).
- Why did the 2027 Medicare Advantage payment increase jump so significantly?
- The increase accounts for rising underlying costs, risk adjustment payments, and quality bonus payments linked to Star Ratings.
- What is the impact of risk scores on the 2027 Medicare Advantage payment increase?
- When risk score trends—influenced by population changes and coding—are included, the effective increase reaches 4.98%.
- How did investors react to the 2027 Medicare Advantage payment increase?
- Investors reacted positively, with shares of major insurers like UnitedHealth, Humana, and CVS rising by 8% to 14%.
Join the Conversation: Do you believe these increased payments will improve the quality of care for seniors, or simply increase corporate profits? Share your thoughts in the comments below and share this article with your colleagues in the healthcare sector.
Disclaimer: This article is for informational purposes only and does not constitute financial, legal, or medical advice. Please consult with a licensed professional regarding specific Medicare plan decisions or investment strategies.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
